162 related articles for article (PubMed ID: 21448995)
1. Short duration gluteraldehyde cross linking of decellularized bovine pericardium improves biological response.
Umashankar PR; Arun T; Kumari TV
J Biomed Mater Res A; 2011 Jun; 97(3):311-20. PubMed ID: 21448995
[TBL] [Abstract][Full Text] [Related]
2. Effect of chronic inflammation and immune response on regeneration induced by decellularized bovine pericardium.
Umashankar PR; Arun T; Kumary TV
J Biomed Mater Res A; 2013 Aug; 101(8):2202-9. PubMed ID: 23281204
[TBL] [Abstract][Full Text] [Related]
3. Biocompatibility and calcification of bovine pericardium employed for the construction of cardiac bioprostheses treated with different chemical crosslink methods.
Jorge-Herrero E; Fonseca C; Barge AP; Turnay J; Olmo N; Fernández P; Lizarbe MA; García Páez JM
Artif Organs; 2010 May; 34(5):E168-76. PubMed ID: 20633147
[TBL] [Abstract][Full Text] [Related]
4. Mitigation of calcification and cytotoxicity of a glutaraldehyde-preserved bovine pericardial matrix: improved biocompatibility after extended implantation in the subcutaneous rat model.
Neethling WM; Glancy R; Hodge AJ
J Heart Valve Dis; 2010 Nov; 19(6):778-85. PubMed ID: 21214104
[TBL] [Abstract][Full Text] [Related]
5. Enhanced biostability and biocompatibility of decellularized bovine pericardium, crosslinked with an ultra-low concentration monomeric aldehyde and treated with ADAPT.
Neethling WM; Yadav S; Hodge AJ; Glancy R
J Heart Valve Dis; 2008 Jul; 17(4):456-63; discussion 464. PubMed ID: 18751476
[TBL] [Abstract][Full Text] [Related]
6. Biomechanical characterization of decellularized and cross-linked bovine pericardium.
Oswal D; Korossis S; Mirsadraee S; Wilcox H; Watterson K; Fisher J; Ingham E
J Heart Valve Dis; 2007 Mar; 16(2):165-74. PubMed ID: 17484467
[TBL] [Abstract][Full Text] [Related]
7. Glutaraldehyde treatment elicits toxic response compared to decellularization in bovine pericardium.
Umashankar PR; Mohanan PV; Kumari TV
Toxicol Int; 2012 Jan; 19(1):51-8. PubMed ID: 22736904
[TBL] [Abstract][Full Text] [Related]
8. Decellularized and photooxidatively crosslinked bovine jugular veins as potential tissue engineering scaffolds.
Lü WD; Zhang M; Wu ZS; Hu TH
Interact Cardiovasc Thorac Surg; 2009 Mar; 8(3):301-5. PubMed ID: 19074454
[TBL] [Abstract][Full Text] [Related]
9. Crosslinkage of collagen by polyglycidyl ethers.
Tang Z; Yue Y
ASAIO J; 1995; 41(1):72-8. PubMed ID: 7727825
[TBL] [Abstract][Full Text] [Related]
10. Treatment of bioprosthetic heart valve tissue with long chain alcohol solution to lower calcification potential.
Pathak CP; Adams AK; Simpson T; Phillips RE; Moore MA
J Biomed Mater Res A; 2004 Apr; 69(1):140-4. PubMed ID: 14999761
[TBL] [Abstract][Full Text] [Related]
11. Biostability, durability and calcification of cryopreserved human pericardium after rapid glutaraldehyde-stabilization versus multistep ADAPT(R) treatment in a subcutaneous rat model.
Neethling W; Brizard C; Firth L; Glancy R
Eur J Cardiothorac Surg; 2014 Apr; 45(4):e110-7. PubMed ID: 24431173
[TBL] [Abstract][Full Text] [Related]
12. A multi-step approach in anti-calcification of glutaraldehyde-preserved bovine pericardium.
Neethling WM; Hodge AJ; Clode P; Glancy R
J Cardiovasc Surg (Torino); 2006 Dec; 47(6):711-8. PubMed ID: 17043620
[TBL] [Abstract][Full Text] [Related]
13. Interactions of U937 macrophage-like cells with decellularized pericardial matrix materials: influence of crosslinking treatment.
McDade JK; Brennan-Pierce EP; Ariganello MB; Labow RS; Michael Lee J
Acta Biomater; 2013 Jul; 9(7):7191-9. PubMed ID: 23454057
[TBL] [Abstract][Full Text] [Related]
14. Bioprosthetic cardiac valve degeneration: role of inflammatory and immune reactions.
Gong G; Seifter E; Lyman WD; Factor SM; Blau S; Frater RW
J Heart Valve Dis; 1993 Nov; 2(6):684-93. PubMed ID: 7719511
[TBL] [Abstract][Full Text] [Related]
15. Histological response to injected gluteraldehyde cross-linked bovine collagen based implant in a rat model.
Alkan M; Talim B; Ciftci AO; Senocak ME; Caglar M; Büyükpamukçu N
BMC Urol; 2006 Feb; 6():3. PubMed ID: 16503996
[TBL] [Abstract][Full Text] [Related]
16. Combined anticalcification treatment of bovine pericardium with decellularization and hyaluronic acid derivative.
Zhu D; Jin L; Wang X; Xu L; Liu T
Biomed Mater Eng; 2014; 24(1):741-9. PubMed ID: 24211959
[TBL] [Abstract][Full Text] [Related]
17. Pathological effects of processed bovine pericardial scaffolds--a comparative in vivo evaluation.
Thampi P; Nair D; R L; N V; Venugopal S; Ramachandra U
Artif Organs; 2013 Jul; 37(7):600-5. PubMed ID: 23452255
[TBL] [Abstract][Full Text] [Related]
18. Long-term healing of mildly cross-linked decellularized bovine pericardial aortic patch.
Umashankar PR; Sabareeswaran A; Shenoy SJ
J Biomed Mater Res B Appl Biomater; 2017 Oct; 105(7):2145-2152. PubMed ID: 27417409
[TBL] [Abstract][Full Text] [Related]
19. Lyophilized bovine pericardium treated with a phenethylamine-diepoxide as an alternative to preventing calcification of cardiovascular bioprosthesis: preliminary calcification results.
Aimoli CG; Nogueira GM; Nascimento LS; Baceti A; Leirner AA; Maizato MJ; Higa OZ; Polakiewicz B; Pitombo RN; Beppu MM
Artif Organs; 2007 Apr; 31(4):278-83. PubMed ID: 17437496
[TBL] [Abstract][Full Text] [Related]
20. Histological evaluation of biocompatibility of lyophilized bovine pericardium implanted subcutaneously in rats.
Maizato MJ; Pires MD; Canzian M; Higa OZ; Pitombo RN; Leirner AA
Artif Organs; 2008 Apr; 32(4):268-71. PubMed ID: 18370939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
